Hypera (BSP:HYPE3) Payments of Debt : R$-906 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Hypera Payments of Debt?

Hypera's Payments of Debt for the three months ended in Mar. 2024 was R$-78 Mil.

Hypera's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was R$-906 Mil.

Hypera Payments of Debt Historical Data

The historical data trend for Hypera's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Payments of Debt Chart

Hypera Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Payments of Debt

Get a 7-Day Free Trial

-123.40

-98.98

-519.69

-409.55

-1,925.18

Hypera Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Payments of Debt	Get a 7-Day Free Trial															-1,096.50	-48.00	-133.02	-647.65	-77.78

Hypera Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-906 Mil.

Hypera Payments of Debt Related Terms

Thank you for viewing the detailed overview of Hypera's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera (BSP:HYPE3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » Payments of Debt

Comparable Companies

Traded in Other Exchanges

HYPMY:USA HM6A:Germany

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera (BSP:HYPE3) Headlines

No Headlines